Using a Multilingual AI Care Agent to Reduce Disparities in Colorectal Cancer Screening for Higher Fecal Immunochemical Test Adoption Among Spanish-Speaking Patients: Retrospective Analysis.

Meenesh Bhimani¹, R Hal Baker², Markel Sanz Ausin¹, Gerald Meixiong¹, Rae Lasko¹, Mariska Raglow-Defranco¹, Alex Miller¹, Subhabrata Mukherjee¹, Saad Godil¹, Anderson Cook¹, Jonathan D Agnew³, Ashish Atreja⁴

¹Hippocratic AI, Palo Alto, CA, United States.

²WellSpan Health, York, PA, United States.

³School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.

⁴University of California Davis Health, Davis, CA, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND: Colorectal cancer (CRC) screening rates remain disproportionately low among Hispanic and Latino populations compared to non-Hispanic White populations. While artificial intelligence (AI) shows promise in health care delivery, concerns exist that AI-based interventions may disadvantage non-English-speaking populations due to biases in development and deployment. OBJECTIVE: This study a…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.